Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection margin.
CONCLUSION: Adjuvant therapy may improve overall survival and recurrence-free survival after margin-positive resection. This pattern seems most pronounced with adjuvant chemoradiotherapy in non-responders to neoadjuvant chemotherapy.
PMID: 32990343 [PubMed - as supplied by publisher]
Source: The British Journal of Surgery - Category: Surgery Authors: Bott RK, Beckmann K, Zylstra J, Wilkinson MJ, Knight WRC, Baker CR, Kelly M, Maisey N, Qureshi A, Sevitt T, Van Hemelrijck M, Smyth EC, Allum WH, Lagergren J, Gossage JA, Cunningham D, Davies AR, Guy's and St Thomas' Oesophagogastric Research Group Tags: Br J Surg Source Type: research
More News: Adenocarcinoma | Chemotherapy | Databases & Libraries | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Surgery | UK Health